Cargando…
Prevalence and Risk Factors for Adrenal Insufficiency in Patients with Multiple Myeloma Receiving Long-Term Chemotherapy including Corticosteroids: A Retrospective Cohort Study
Multiple myeloma (MM) is the second most common hematologic malignancy and requires long-term and high-dose corticosteroid-based chemotherapy. The aim of this study was to investigate the prevalence and clinical predictors of corticosteroid-associated adrenal insufficiency (AI) in patients with MM r...
Autores principales: | Yoon, Jee Hee, Ahn, Seo-Yeon, Jung, Sung-Hoon, Lee, Je-Jung, Choi, Wonsuk, Park, Ji Yong, Hong, A Ram, Kim, Hee Kyung, Kang, Ho-Cheol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687836/ https://www.ncbi.nlm.nih.gov/pubmed/34938804 http://dx.doi.org/10.1155/2021/2330417 |
Ejemplares similares
-
Inhaled Corticosteroids and Secondary Adrenal Insufficiency
por: Sannarangappa, Vishnu, et al.
Publicado: (2014) -
Time to Care for Adrenal Insufficiency in Cancer Patients
por: Kim, Jung Hee
Publicado: (2022) -
Effectiveness of darbepoetin alfa in multiple myeloma patients receiving chemotherapy including novel agents
por: Lee, Sung-Eun, et al.
Publicado: (2018) -
Adrenal Insufficiency in Children With Nephrotic Syndrome on Corticosteroid Treatment
por: Abu Bakar, Karmila, et al.
Publicado: (2020) -
Residual endogenous corticosteroid production in patients with adrenal insufficiency
por: Vulto, Annet, et al.
Publicado: (2019)